# clm_F9273E2418F6

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: research_and_development  
value: 11,143,000,000 United States dollar  
valid_from: 2020-12-31  
valid_to: 2021-12-31  
published: 2021-02-10  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_65C9EBE9DAD1  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb research and development: 11,143,000,000 United States dollar", as of 2020-12-31 (until 2021-12-31). Claim clm_F9273E2418F6, https://asof.is/claim/clm_F9273E2418F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2020, filed 2021-02-10  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm (primary, SEC EDGAR 10-K FY2020, published 2021-02-10)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 6,148,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_F9273E2418F6](/claim/clm_F9273E2418F6.md) | [clm_9F214679BDA4](/claim/clm_9F214679BDA4.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
